rs35609199

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_000823.4(GHRHR):​c.598-10T>C variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0468 in 1,612,620 control chromosomes in the GnomAD database, including 4,343 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.10 ( 1704 hom., cov: 32)
Exomes 𝑓: 0.041 ( 2639 hom. )

Consequence

GHRHR
NM_000823.4 intron

Scores

2
Splicing: ADA: 0.00009625
2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:4

Conservation

PhyloP100: -1.29

Publications

7 publications found
Variant links:
Genes affected
GHRHR (HGNC:4266): (growth hormone releasing hormone receptor) This gene encodes a receptor for growth hormone-releasing hormone. Binding of this hormone to the receptor leads to synthesis and release of growth hormone. Mutations in this gene have been associated with isolated growth hormone deficiency (IGHD), also known as Dwarfism of Sindh, a disorder characterized by short stature. [provided by RefSeq, Jun 2010]
GHRHR Gene-Disease associations (from GenCC):
  • isolated growth hormone deficiency type IB
    Inheritance: AR Classification: DEFINITIVE, SUPPORTIVE Submitted by: Laboratory for Molecular Medicine, Orphanet
  • isolated growth hormone deficiency, type 4
    Inheritance: AR Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.91).
BP6
Variant 7-30973975-T-C is Benign according to our data. Variant chr7-30973975-T-C is described in ClinVar as Benign. ClinVar VariationId is 360031.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.271 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
GHRHRNM_000823.4 linkc.598-10T>C intron_variant Intron 6 of 12 ENST00000326139.7 NP_000814.2 Q02643A0A090N8Y6

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
GHRHRENST00000326139.7 linkc.598-10T>C intron_variant Intron 6 of 12 1 NM_000823.4 ENSP00000320180.2 Q02643

Frequencies

GnomAD3 genomes
AF:
0.105
AC:
15914
AN:
151694
Hom.:
1700
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.275
Gnomad AMI
AF:
0.114
Gnomad AMR
AF:
0.0565
Gnomad ASJ
AF:
0.0817
Gnomad EAS
AF:
0.0696
Gnomad SAS
AF:
0.0915
Gnomad FIN
AF:
0.0312
Gnomad MID
AF:
0.136
Gnomad NFE
AF:
0.0290
Gnomad OTH
AF:
0.0872
GnomAD2 exomes
AF:
0.0619
AC:
15392
AN:
248662
AF XY:
0.0600
show subpopulations
Gnomad AFR exome
AF:
0.279
Gnomad AMR exome
AF:
0.0369
Gnomad ASJ exome
AF:
0.0784
Gnomad EAS exome
AF:
0.0742
Gnomad FIN exome
AF:
0.0325
Gnomad NFE exome
AF:
0.0306
Gnomad OTH exome
AF:
0.0604
GnomAD4 exome
AF:
0.0408
AC:
59557
AN:
1460808
Hom.:
2639
Cov.:
33
AF XY:
0.0421
AC XY:
30607
AN XY:
726740
show subpopulations
African (AFR)
AF:
0.283
AC:
9461
AN:
33476
American (AMR)
AF:
0.0393
AC:
1757
AN:
44720
Ashkenazi Jewish (ASJ)
AF:
0.0756
AC:
1977
AN:
26134
East Asian (EAS)
AF:
0.0511
AC:
2030
AN:
39694
South Asian (SAS)
AF:
0.0941
AC:
8116
AN:
86252
European-Finnish (FIN)
AF:
0.0342
AC:
1795
AN:
52554
Middle Eastern (MID)
AF:
0.113
AC:
651
AN:
5766
European-Non Finnish (NFE)
AF:
0.0271
AC:
30162
AN:
1111826
Other (OTH)
AF:
0.0597
AC:
3608
AN:
60386
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.471
Heterozygous variant carriers
0
2910
5820
8729
11639
14549
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
1338
2676
4014
5352
6690
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.105
AC:
15934
AN:
151812
Hom.:
1704
Cov.:
32
AF XY:
0.104
AC XY:
7740
AN XY:
74180
show subpopulations
African (AFR)
AF:
0.275
AC:
11369
AN:
41320
American (AMR)
AF:
0.0564
AC:
862
AN:
15274
Ashkenazi Jewish (ASJ)
AF:
0.0817
AC:
283
AN:
3466
East Asian (EAS)
AF:
0.0698
AC:
359
AN:
5144
South Asian (SAS)
AF:
0.0910
AC:
433
AN:
4760
European-Finnish (FIN)
AF:
0.0312
AC:
331
AN:
10596
Middle Eastern (MID)
AF:
0.133
AC:
39
AN:
294
European-Non Finnish (NFE)
AF:
0.0290
AC:
1971
AN:
67936
Other (OTH)
AF:
0.0867
AC:
183
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.500
Heterozygous variant carriers
0
611
1222
1833
2444
3055
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
172
344
516
688
860
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0815
Hom.:
391
Bravo
AF:
0.116
Asia WGS
AF:
0.100
AC:
350
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
Jun 09, 2021
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

GHRHR-related disorder Benign:1
Nov 06, 2019
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -

Isolated growth hormone deficiency type IB Benign:1
Jan 13, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.91
CADD
Benign
1.0
DANN
Benign
0.40
PhyloP100
-1.3
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
dbscSNV1_ADA
Benign
0.000096
dbscSNV1_RF
Benign
0.0060
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs35609199; hg19: chr7-31013590; API